A detailed history of Claret Asset Management Corp transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 11,330 shares of PMN stock, worth $10,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,330
Previous 10,830 4.62%
Holding current value
$10,197
Previous $16,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $2.27 $600 - $1,135
500 Added 4.62%
11,330 $14,000
Q3 2023

Nov 13, 2023

SELL
$1.52 - $6.19 $2,280 - $9,285
-1,500 Reduced 12.17%
10,830 $22,000
Q3 2022

Nov 14, 2022

BUY
$4.99 - $9.25 $61,526 - $114,052
12,330 New
12,330 $75,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.